ATA714478A - Xanthinderivate - Google Patents

Xanthinderivate

Info

Publication number
ATA714478A
ATA714478A AT714478A AT714478A ATA714478A AT A714478 A ATA714478 A AT A714478A AT 714478 A AT714478 A AT 714478A AT 714478 A AT714478 A AT 714478A AT A714478 A ATA714478 A AT A714478A
Authority
AT
Austria
Prior art keywords
xantine
derivatives
xantine derivatives
Prior art date
Application number
AT714478A
Other languages
English (en)
Other versions
AT363491B (de
Inventor
Sten Hakan Axel Mag Bergstrand
Per Gunnar Kjellin
Carl Goeran August Persson
Lars Magnus Soerenby
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco Ab filed Critical Draco Ab
Publication of ATA714478A publication Critical patent/ATA714478A/de
Application granted granted Critical
Publication of AT363491B publication Critical patent/AT363491B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT0714478A 1977-10-14 1978-10-04 Verfahren zur herstellung von neuen 1,3,8trisubstituierten xanthinen und deren salzen AT363491B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7711581A SE416810C (sv) 1977-10-14 1977-10-14 Forfarande for framstellning av xantinderivat med antiallergisk aktivitet

Publications (2)

Publication Number Publication Date
ATA714478A true ATA714478A (de) 1980-09-15
AT363491B AT363491B (de) 1981-08-10

Family

ID=20332576

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0714478A AT363491B (de) 1977-10-14 1978-10-04 Verfahren zur herstellung von neuen 1,3,8trisubstituierten xanthinen und deren salzen

Country Status (21)

Country Link
US (1) US4233303A (de)
EP (1) EP0001735B1 (de)
JP (1) JPS5479296A (de)
AT (1) AT363491B (de)
AU (1) AU521585B2 (de)
CA (1) CA1109470A (de)
CS (1) CS208756B2 (de)
DD (1) DD139855A5 (de)
DE (1) DE2862017D1 (de)
DK (1) DK148260C (de)
FI (1) FI66383C (de)
HK (1) HK6385A (de)
HU (1) HU180219B (de)
IE (1) IE47884B1 (de)
IT (1) IT1109208B (de)
NO (1) NO147562C (de)
NZ (1) NZ188566A (de)
SE (1) SE416810C (de)
SG (1) SG85584G (de)
SU (1) SU755199A3 (de)
ZA (1) ZA785335B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7810947L (sv) * 1978-10-20 1980-04-21 Draco Ab 3-alkylxanthines
SE8002910L (sv) * 1980-04-18 1981-10-19 Draco Ab 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar
US4755517A (en) * 1986-07-31 1988-07-05 Warner-Lambert Company Derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US5298508A (en) * 1988-07-19 1994-03-29 The United States Of America As Represented By The Department Of Health And Human Services Irreversible inhibitors of adenosine receptors
US5321029A (en) * 1988-11-14 1994-06-14 Beecham-Wuelfing Gmbh & Co.K.G. Xanthines
GB8826595D0 (en) * 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
IT1229195B (it) * 1989-03-10 1991-07-25 Poli Ind Chimica Spa Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche.
GB8929208D0 (en) * 1989-12-27 1990-02-28 Almirall Lab New xanthine derivatives
US5047534A (en) * 1990-03-26 1991-09-10 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
US5342841A (en) * 1992-03-12 1994-08-30 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives
US5366977A (en) * 1992-09-29 1994-11-22 The United States Of America, As Represented By The Department Of Health And Human Services Method of treating cystic fibrosis using 8-cyclopentyl-1,3-dipropylxanthine or xanthine amino congeners
US5395836A (en) * 1993-04-07 1995-03-07 Kyowa Hakko Kogyo Co., Ltd. 8-tricycloalkyl xanthine derivatives
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5661153A (en) * 1994-07-19 1997-08-26 Japan Energy Corporation 1-arylpyrimidine derivatives and pharmaceutical use thereof
DE69531506T2 (de) * 1994-12-13 2004-06-24 Euroceltique S.A. Arylthioxanthine
JP2001523213A (ja) * 1994-12-13 2001-11-20 ユーロ−セルティーク，エス．エイ． 三置換チオキサンチン類
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) * 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
EP1620107A1 (de) 2003-04-25 2006-02-01 Novacardia, Inc. Methode zur verbesserung der diurese bei patienten mit eingeschränkter nierenfunktion
US20050239759A1 (en) * 2004-04-16 2005-10-27 Lauren Otsuki Method of treatment of disease using an adenosine A1 receptor antagonist and an aldosterone inhibitor
US20070049757A1 (en) * 2005-08-26 2007-03-01 Rieger Jayson M Methods for the synthesis of substituted amino uracils

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1911279A1 (de) * 1969-03-05 1970-11-12 Eckert Dr Theodor Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen
US3900474A (en) * 1973-05-14 1975-08-19 Kendall & Co Trifluoroalkyl, fluorobenzyl, pentafluorobenzyl, fluorobenzenesulfonyl, and pentafluorobenzenesulfonyl theophyllines
US4061753A (en) * 1976-02-06 1977-12-06 Interx Research Corporation Treating psoriasis with transient pro-drug forms of xanthine derivatives
US4120947A (en) * 1976-03-31 1978-10-17 Cooper Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases
CA1077932A (en) 1976-03-31 1980-05-20 Berlex Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases

Also Published As

Publication number Publication date
SE7711581L (sv) 1979-04-15
SE416810C (sv) 1982-07-19
IE782041L (en) 1979-04-14
FI66383C (fi) 1984-10-10
HK6385A (en) 1985-02-01
NO147562C (no) 1983-05-18
CS208756B2 (en) 1981-09-15
HU180219B (en) 1983-02-28
DE2862017D1 (en) 1982-10-28
NO147562B (no) 1983-01-24
EP0001735B1 (de) 1982-09-01
FI66383B (fi) 1984-06-29
AU4036578A (en) 1980-04-17
SG85584G (en) 1985-06-07
DK453778A (da) 1979-04-15
AT363491B (de) 1981-08-10
ZA785335B (en) 1979-09-26
CA1109470A (en) 1981-09-22
US4233303A (en) 1980-11-11
DK148260C (da) 1986-02-10
SU755199A3 (en) 1980-08-07
IE47884B1 (en) 1984-07-11
NZ188566A (en) 1984-07-06
NO783471L (no) 1979-04-18
IT7851499A0 (it) 1978-10-13
AU521585B2 (en) 1982-04-22
IT1109208B (it) 1985-12-16
SE416810B (sv) 1981-02-09
EP0001735A1 (de) 1979-05-02
DD139855A5 (de) 1980-01-23
JPS5479296A (en) 1979-06-25
FI783126A7 (fi) 1979-04-15
DK148260B (da) 1985-05-20

Similar Documents

Publication Publication Date Title
SE7805879L (sv) Mevalonolaktonderivat
PT68458A (pt) Triphenylalkene derivatives
SE7803475L (sv) Hallare for pasar
ATA714478A (de) Xanthinderivate
SE7803476L (sv) Hallare for pasar
SE7803057L (sv) Bensimidazolderivat
DK543178A (da) Thiodydantoinderivater
SE7804446L (sv) Tienamycinderivat
FI783333A7 (fi) Stommadrass foer liggmoebel
SE7712754L (sv) Bervegg for rorslingor
SE7801997L (sv) Dipeptidderivat
SE7805260L (sv) Alkylendiaminderivat
SE7800982L (sv) Meta-sulfonamido-bensamid-derivat
SE7812411L (sv) Instas for eldstad
PT67561A (de) Neue aminoalkoxyphenyl-derivate
SE7805140L (sv) Bensimidazolderivat
FI783393A7 (fi) 2-imino-imidazolidinderivat
SE7801312L (sv) Oxadiazolopyrimidin-derivat
BE863947R (fr) Phenyl-amidines substituees
SE7813204L (sv) Snabbstal
FI780343A7 (fi) Oxadiazolopyrimidinderivat
SE7803419L (sv) Kinazolinderivat
BR7808456A (pt) Novos derivados de pirazina
SE446529B (sv) Bis(nitrosoureido)-polyl-derivat
IT1098350B (it) Derivati prostaglandinici

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee